Boeing doesn't eclipse army oversight of FCS: General

Article Abstract:

Future Combat Systems (FCS) development and acquisition program involves the Army in every act of it and the military force is having enough control over the program to the Boeing Company. Boeing and Science Applications International Corp. are those systems, which manage the FCS by supplying hardware, and by choosing which defense contractors would build the components that would fit into FCS.

Computer and Data Processing Services, Services development, Computer services industry, Information technology services industry, Aerospace industry, Boeing Co., BA, Company service development, Service development, Science Applications International Corp.

---

New procurement guidelines might favor lower-cost systems

Article Abstract:

The latest defense Capabilities Review (DCR) a new means of deciding what defense-industry products provides the best capability to the military and favors cheaper systems. According to the briefers, the new system is more responsive to the needs of the combatant commanders as their input would be included much earlier in the development process.

Forecasts, trends, outlooks, Product information, Forecasts and trends, Market trend/market analysis, Defense industry, Military equipment, Defence industry, Military paraphernalia, Mechanization, Military

---

V-22 Osprey glitch fixed, critics unconvinced

Article Abstract:

A correction is devised by software engineers to prevent the V-22 Osprey tilt-rotor from entering uncontrolled yawing. However critics view the tilt-rotor as fatally flawed due to its earlier crashes.

Product enhancement, Helicopters, V-22 (Aircraft)

Similar abstracts:

• Abstracts: S election does not remove relevance of SFAS No. 109. S corporations allow flexibility in dealing with passive activities
• Abstracts: Savings and loan ownership structure and expense-preference. A note on savings and loan ownership structure and expense preference: A re-examination
• Abstracts: Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Enhancement of therapeutic protein in vivo activities through glycoengineering
• Abstracts: No escaping personal liability. Unaudited accounts: The lurking hazards. Taxing slip-ups
• Abstracts: Sorting things out: valuation of new firms in uncertain markets. The influence of the financial press on stockholder wealth: The case of corporate governance

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.